This report aims to provide a comprehensive presentation of the global market for Tumor Immunity Therapy study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.

Global Tumor Immunity Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tumor Immunity Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immune Checkpoint Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tumor Immunity Therapy include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc. and IMVAQ Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

The study provides the Tumor Immunity Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Segmental Outline:

Global Tumor Immunity Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tumor Immunity Therapy Market Segment Percentages, by Type, 2021 (%)

Immune Checkpoint Inhibitor

Cytokine Immunotherapy

Cancer Vaccine

Car-t Cell Therapy

Others

Global Tumor Immunity Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tumor Immunity Therapy Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Global Tumor Immunity Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tumor Immunity Therapy Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tumor Immunity Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tumor Immunity Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bristol-Myers Squibb

Merck & Co., Inc.

Roche AG

AstraZeneca, Plc

Sanofi S.A.

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc.

IMVAQ Therapeutics

Arch Oncology

Juno Therapeutics

Refuge

Lepu Biopharma

Genoimmune

TCR Cure

This Report Addresses:

– Market Intelligence enables effective decision-making

– Market estimates and forecasts from 2022 to 2028

– Growth opportunities and trend analysis

– Segment and regional revenue forecast for market evaluation

– Competitive strategy and analysis of market segments

– List of product innovations to stay on top.

– The impact of COVID-19 and how to survive in these fast-growing markets.

1 Introduction to Research & Analysis Reports

1.1 Tumor Immunity Therapy Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Tumor Immunity Therapy Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Tumor Immunity Therapy Overall Market Size

2.1 Global Tumor Immunity Therapy Market Size: 2021 VS 2028

2.2 Global Tumor Immunity Therapy Market Size, Prospects & Forecasts: 2017-2028

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top Tumor Immunity Therapy Players in Global Market

3.2 Top Global Tumor Immunity Therapy Companies Ranked by Revenue

3.3 Global Tumor Immunity Therapy Revenue by Companies

3.4 Top 3 and Top 5 Tumor Immunity Therapy Companies in Global Market, by Revenue in 2021

3.5 Global Companies Tumor Immunity Therapy Product Type

3.6 Tier 1, Tier 2 and Tier 3 Tumor Immunity Therapy Players in Global Market

3.6.1 List of Global Tier 1 Tumor Immunity Therapy Companies

3.6.2 List of Global Tier 2 and Tier 3 Tumor Immunity Therapy Companies

4 Market Sights by Product

4.1 Overview

4.1.1 by Type - Global Tumor Immunity Therapy Market Size Markets, 2021 & 2028

4.1.2 Immune Checkpoint Inhibitor

4.1.3 Cytokine Immunotherapy

4.1.4 Cancer Vaccine

4.1.5 Car-t Cell Therapy

4.1.6 Others

4.2 By Type - Global Tumor Immunity Therapy Revenue & Forecasts

4.2.1 By Type - Global Tumor Immunity Therapy Revenue, 2017-2022

4.2.2 By Type - Global Tumor Immunity Therapy Revenue, 2023-2028

4.2.3 By Type - Global Tumor Immunity Therapy Revenue Market Share, 2017-2028

5 Sights by Application

5.1 Overview

5.1.1 By Application - Global Tumor Immunity Therapy Market Size, 2021 & 2028

5.1.2 Hospital

5.1.3 Clinic

5.2 By Application - Global Tumor Immunity Therapy Revenue & Forecasts

5.2.1 By Application - Global Tumor Immunity Therapy Revenue, 2017-2022

5.2.2 By Application - Global Tumor Immunity Therapy Revenue, 2023-2028

5.2.3 By Application - Global Tumor Immunity Therapy Revenue Market Share, 2017-2028

6 Sights by Region

6.1 By Region - Global Tumor Immunity Therapy Market Size, 2021 & 2028

6.2 By Region - Global Tumor Immunity Therapy Revenue & Forecasts

6.2.1 By Region - Global Tumor Immunity Therapy Revenue, 2017-2022

6.2.2 By Region - Global Tumor Immunity Therapy Revenue, 2023-2028

6.2.3 By Region - Global Tumor Immunity Therapy Revenue Market Share, 2017-2028

6.3 North America

6.3.1 By Country - North America Tumor Immunity Therapy Revenue, 2017-2028

6.3.2 US Tumor Immunity Therapy Market Size, 2017-2028

6.3.3 Canada Tumor Immunity Therapy Market Size, 2017-2028

6.3.4 Mexico Tumor Immunity Therapy Market Size, 2017-2028

6.4 Europe

6.4.1 By Country - Europe Tumor Immunity Therapy Revenue, 2017-2028

6.4.2 Germany Tumor Immunity Therapy Market Size, 2017-2028

6.4.3 France Tumor Immunity Therapy Market Size, 2017-2028

6.4.4 U.K. Tumor Immunity Therapy Market Size, 2017-2028

6.4.5 Italy Tumor Immunity Therapy Market Size, 2017-2028

6.4.6 Russia Tumor Immunity Therapy Market Size, 2017-2028

6.4.7 Nordic Countries Tumor Immunity Therapy Market Size, 2017-2028

6.4.8 Benelux Tumor Immunity Therapy Market Size, 2017-2028

6.5 Asia

6.5.1 By Region - Asia Tumor Immunity Therapy Revenue, 2017-2028

6.5.2 China Tumor Immunity Therapy Market Size, 2017-2028

6.5.3 Japan Tumor Immunity Therapy Market Size, 2017-2028

6.5.4 South Korea Tumor Immunity Therapy Market Size, 2017-2028

6.5.5 Southeast Asia Tumor Immunity Therapy Market Size, 2017-2028

6.5.6 India Tumor Immunity Therapy Market Size, 2017-2028

6.6 South America

6.6.1 By Country - South America Tumor Immunity Therapy Revenue, 2017-2028

6.6.2 Brazil Tumor Immunity Therapy Market Size, 2017-2028

6.6.3 Argentina Tumor Immunity Therapy Market Size, 2017-2028

6.7 Middle East & Africa

6.7.1 By Country - Middle East & Africa Tumor Immunity Therapy Revenue, 2017-2028

6.7.2 Turkey Tumor Immunity Therapy Market Size, 2017-2028

6.7.3 Israel Tumor Immunity Therapy Market Size, 2017-2028

6.7.4 Saudi Arabia Tumor Immunity Therapy Market Size, 2017-2028

6.7.5 UAE Tumor Immunity Therapy Market Size, 2017-2028

7 Players Profiles

7.1 Bristol-Myers Squibb

7.1.1 Bristol-Myers Squibb Corporate Summary

7.1.2 Bristol-Myers Squibb Business Overview

7.1.3 Bristol-Myers Squibb Tumor Immunity Therapy Major Product Offerings

7.1.4 Bristol-Myers Squibb Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.1.5 Bristol-Myers Squibb Key News

7.2 Merck & Co., Inc.

7.2.1 Merck & Co., Inc. Corporate Summary

7.2.2 Merck & Co., Inc. Business Overview

7.2.3 Merck & Co., Inc. Tumor Immunity Therapy Major Product Offerings

7.2.4 Merck & Co., Inc. Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.2.5 Merck & Co., Inc. Key News

7.3 Roche AG

7.3.1 Roche AG Corporate Summary

7.3.2 Roche AG Business Overview

7.3.3 Roche AG Tumor Immunity Therapy Major Product Offerings

7.3.4 Roche AG Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.3.5 Roche AG Key News

7.4 AstraZeneca, Plc

7.4.1 AstraZeneca, Plc Corporate Summary

7.4.2 AstraZeneca, Plc Business Overview

7.4.3 AstraZeneca, Plc Tumor Immunity Therapy Major Product Offerings

7.4.4 AstraZeneca, Plc Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.4.5 AstraZeneca, Plc Key News

7.5 Sanofi S.A.

7.5.1 Sanofi S.A. Corporate Summary

7.5.2 Sanofi S.A. Business Overview

7.5.3 Sanofi S.A. Tumor Immunity Therapy Major Product Offerings

7.5.4 Sanofi S.A. Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.5.5 Sanofi S.A. Key News

7.6 Dendreon Pharmaceuticals

7.6.1 Dendreon Pharmaceuticals Corporate Summary

7.6.2 Dendreon Pharmaceuticals Business Overview

7.6.3 Dendreon Pharmaceuticals Tumor Immunity Therapy Major Product Offerings

7.6.4 Dendreon Pharmaceuticals Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.6.5 Dendreon Pharmaceuticals Key News

7.7 Novartis

7.7.1 Novartis Corporate Summary

7.7.2 Novartis Business Overview

7.7.3 Novartis Tumor Immunity Therapy Major Product Offerings

7.7.4 Novartis Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.7.5 Novartis Key News

7.8 Gilead Sciences Inc.

7.8.1 Gilead Sciences Inc. Corporate Summary

7.8.2 Gilead Sciences Inc. Business Overview

7.8.3 Gilead Sciences Inc. Tumor Immunity Therapy Major Product Offerings

7.8.4 Gilead Sciences Inc. Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.8.5 Gilead Sciences Inc. Key News

7.9 IMVAQ Therapeutics

7.9.1 IMVAQ Therapeutics Corporate Summary

7.9.2 IMVAQ Therapeutics Business Overview

7.9.3 IMVAQ Therapeutics Tumor Immunity Therapy Major Product Offerings

7.9.4 IMVAQ Therapeutics Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.9.5 IMVAQ Therapeutics Key News

7.10 Arch Oncology

7.10.1 Arch Oncology Corporate Summary

7.10.2 Arch Oncology Business Overview

7.10.3 Arch Oncology Tumor Immunity Therapy Major Product Offerings

7.10.4 Arch Oncology Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.10.5 Arch Oncology Key News

7.11 Juno Therapeutics

7.11.1 Juno Therapeutics Corporate Summary

7.11.2 Juno Therapeutics Business Overview

7.11.3 Juno Therapeutics Tumor Immunity Therapy Major Product Offerings

7.11.4 Juno Therapeutics Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.11.5 Juno Therapeutics Key News

7.12 Refuge

7.12.1 Refuge Corporate Summary

7.12.2 Refuge Business Overview

7.12.3 Refuge Tumor Immunity Therapy Major Product Offerings

7.12.4 Refuge Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.12.5 Refuge Key News

7.13 Lepu Biopharma

7.13.1 Lepu Biopharma Corporate Summary

7.13.2 Lepu Biopharma Business Overview

7.13.3 Lepu Biopharma Tumor Immunity Therapy Major Product Offerings

7.13.4 Lepu Biopharma Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.13.5 Lepu Biopharma Key News

7.14 Genoimmune

7.14.1 Genoimmune Corporate Summary

7.14.2 Genoimmune Business Overview

7.14.3 Genoimmune Tumor Immunity Therapy Major Product Offerings

7.14.4 Genoimmune Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.14.5 Genoimmune Key News

7.15 TCR Cure

7.15.1 TCR Cure Corporate Summary

7.15.2 TCR Cure Business Overview

7.15.3 TCR Cure Tumor Immunity Therapy Major Product Offerings

7.15.4 TCR Cure Tumor Immunity Therapy Revenue in Global Market (2017-2022)

7.15.5 TCR Cure Key News

8 Conclusion

9 Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)